Revised SPC: Octagam 10% (human normal immunoglobulin) -

Revised SPC: Octagam 10% (human normal immunoglobulin)
Information type: Drug prescribing
Source: Glenmark Pharmaceuticals Europe Ltd
Specialities: Neurological disorders
Summary
The SPC has been revised to include a new license indication: It has now been approved for use in chronic inflammatory demyelinating polyneuropathy (CIDP).
UKMi comment
The Department of Health Clinical Guideline for immunoglobulin use lists chronic inflammatory demyelinating polyneuropathy (CIDP) as an approved indication.
Related links:

Terms and Conditions

For feedback or enquiries relating to this service please email: medicinesresources@gstt.nhs.uk